ACS Logo Analytical Control Systems, Inc

Analytical Control Systems, Inc.


 

Email ACS

info@analyticalcontrols.com

Phone ACS

317-841-0458

Fax ACS

317-841-3186

Mail ACS

Analytical Control Systems, Inc.

9058 Technology Drive
Fishers, IN 46038

 


All WebPages' contents are © 2002-2004 Analytical Control Systems, Inc.
Many of Analytical Control Systems, Inc. products are covered by US and foreign patents or patents pending.

Platelet Depleted Plasma, Spectra™ APTT and Low Molecular Weight Heparin

Evaluation of Propyl Gallate APTT to Monitor Low Molecular Weight Heparin Using Platelet Depleted Plasma

By R Speck, D Bonderman, C Speck and J Griep Nov 15, 1996

Analytical Control Systems, Inc. has developed a new, patented highly sensitive Activated Partial Thromboplastin Time (APTT) assay. A new plasma preparation, platelet depleted plasma (PDP), is used for this test. Filtering platelet poor plasma (PPP) with a 0.22 micron double Millipore filter depletes the plasma of virtually all platelets and platelet fragments, increasing the sensitivity of the assay. A small, known concentration of phospholipid (PL) is added to the propyl gallate (PG) APTT reagent. The concentration of PL to optimize the sensitivity of this test has been determined. The effect of addition of various amounts of PL to the propyl gallate APTT for monitoring low molecular weight (LMW) heparin is shown below.

 

Effect of Phospholipid on Propyl Gallate APTT for Monitoring Low Molecular Weight Heparin

wpe17.jpg (18861 bytes)

 

 

 

 

 

 

 

 

Sensitivity of Commercial APTT Reagents to Unfractionated Heparin

Heparin u/ml PG APTT 100 ug PF3/ml PG APTT 10 ug PF3/ml Dade Actin FS Dade Actin FSL O-T APTT Auto O-T APTT LS

0

25.5

40.4

27.5

25.5

27.9

29.5

0.2

41.5

92.5

58

55.9

56

54.9

0.4

61.5

207

108.4

82.6

95.3

103.4

0.6

88

316.4

208.5

159.9

149.5

206

The two major outcomes of this research is decreased variability in the new plasma preparation technique and improved sensitivity of the propyl gallate APTT to both unfractionated and LMW heparin.

 

wpe1.jpg (5287 bytes) Return to APTT Research Index